Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 901253, 8 pages
http://dx.doi.org/10.1155/2013/901253
Clinical Study

Adduct of Malondialdehyde to Hemoglobin: A New Marker of Oxidative Stress That Is Associated with Significant Morbidity in Preterm Infants

1Département de Néonatologie, CHU Angers, 49100 Angers, France
2Département de Néonatologie, Hôpital de la Croix Rousse, Hospices Civils de Lyon, 69004 Lyon, France
3Centre de Recherche en Nutrition Humaine Rhône-Alpes, Centre hospitalier Lyon-Sud, 69310 Pierrre Bénite, France
4Département de Biostatistique, Hospices Civils de Lyon, 69003 Lyon, France
5Université Claude Bernard Lyon I, 69100 Villeurbanne, France
6CNRS UMR5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique Santé, 69310 Pierre-Bénite, France
7Centre de Biologie Sud, UF Nutrition et Métabolisme, Centre hospitalier Lyon-Sud, Hospices Civils de Lyon, 69310 Pierrre Bénite, France

Received 8 February 2013; Revised 28 March 2013; Accepted 29 March 2013

Academic Editor: Kota V. Ramana

Copyright © 2013 Cécile Cipierre et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Cécile Cipierre, Stéphane Haÿs, Delphine Maucort-Boulch, Jean-Paul Steghens, and Jean-Charles Picaud, “Adduct of Malondialdehyde to Hemoglobin: A New Marker of Oxidative Stress That Is Associated with Significant Morbidity in Preterm Infants,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 901253, 8 pages, 2013. doi:10.1155/2013/901253